Thyroid Cancer Treatment Market : By Treatment Type (Iodine Therapy, Thyroxin Treatment, Chemotherapy (Cisplatin, Doxorubicin), By Drugs (Levothyroxine, Radioiodine), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography 

Purchase Option

$ 4400
$ 6600
$ 8900

Thyroid Cancer Treatment Market size was valued at USD 1,672.1 million in 2022, growing at a significant CAGR of 5.1% from 2023 to 2029. The global market provides a detailed overview and which can be segmented by treatment type, drugs, distribution channel, and region. By treatment type, the market has been segmented into iodine therapy, thyroxin treatment, and chemotherapy (cisplatin, doxorubicin)). By treatment type, the chemotherapy segment held the majority of the revenue share of the thyroid cancer treatment market in the historic period and is anticipated to have led the segment growth rate over the forecasted period due to an increase in the demand for chemotherapy in various types of cancer. By drugs, the thyroid cancer treatment market has been segmented into levothyroxine and radioiodine. By drugs, the radioiodine segment held the largest revenue share of the thyroid cancer treatment market in these current years and is expected to have the fastest growth rate over the forecasted period. By distribution channel, the market has been segmented into hospital pharmacies, retail pharmacies, and others. By treatment type, the chemotherapy segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate.  

 

Thyroid Cancer Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Thyroid Cancer Treatment Market Dynamics

The increasing prevalence of thyroid cancer globally, along with the rising investment in healthcare expenditure are the primary driver for the growth of the thyroid cancer treatment market. Furthermore, the increasing geriatric population and the growing middle-class population in emerging economies are on a global level further expected to fuel the market in current years. For instance, as per the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is projected to get double nearly to 1,500 million.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Thyroid Cancer Treatment Market Segmentation

By Treatment Type
  • Iodine Therapy
  • Thyroxin Treatment
  • Chemotherapy
  • Drugs
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
By Geography
  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Frequently Asked Questions

Based on treatment type, the chemotherapy segment held the majority of the revenue share of the thyroid cancer treatment market in the historic period and is anticipated to have led the segment growth rate over the forecasted period due to an increase in the demand for chemotherapy in various types of cancer.

High cost of diagnosis, and unawareness among people in under-developed and developing countries.

The global thyroid cancer treatment market size is expected to be valued at USD 1,672.1 million in 2021.

North America is estimated to have the largest share of the global thyroid cancer treatment market in terms of revenue, owing to the rising healthcare investment, accompanied by the presence of leading healthcare service providers, and the growing number of cancer patients in the region.

1.Executive Summary
2.Global Thyroid Cancer Treatment Market Introduction 
2.1.Global Thyroid Cancer Treatment Market  - Taxonomy
2.2.Global Thyroid Cancer Treatment Market  - Definitions
2.2.1.Treatment Type
2.2.2.Drugs
2.2.3.Distribution Channel
2.2.4.Region
3.Global Thyroid Cancer Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Thyroid Cancer Treatment Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Thyroid Cancer Treatment Market  By Treatment Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Iodine Therapy
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Thyroxin Treatment
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Chemotherapy
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Cisplatin
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Doxorubicin
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Thyroid Cancer Treatment Market  By Drugs, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Levothyroxine
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Radioiodine
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Thyroid Cancer Treatment Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Thyroid Cancer Treatment Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Thyroid Cancer Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Treatment Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Iodine Therapy
9.1.2.Thyroxin Treatment
9.1.3.Chemotherapy
9.1.4.Cisplatin
9.1.5.Doxorubicin
9.2.  Drugs Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Levothyroxine
9.2.2.Radioiodine
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Thyroid Cancer Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Iodine Therapy
10.1.2.Thyroxin Treatment
10.1.3.Chemotherapy
10.1.4.Cisplatin
10.1.5.Doxorubicin
10.2.  Drugs Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Levothyroxine
10.2.2.Radioiodine
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Thyroid Cancer Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Iodine Therapy
11.1.2.Thyroxin Treatment
11.1.3.Chemotherapy
11.1.4.Cisplatin
11.1.5.Doxorubicin
11.2.  Drugs Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Levothyroxine
11.2.2.Radioiodine
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Thyroid Cancer Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Iodine Therapy
12.1.2.Thyroxin Treatment
12.1.3.Chemotherapy
12.1.4.Cisplatin
12.1.5.Doxorubicin
12.2.  Drugs Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Levothyroxine
12.2.2.Radioiodine
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Thyroid Cancer Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Iodine Therapy
13.1.2.Thyroxin Treatment
13.1.3.Chemotherapy
13.1.4.Cisplatin
13.1.5.Doxorubicin
13.2.  Drugs Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Levothyroxine
13.2.2.Radioiodine
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.Hoffmann-La Roche Ltd.
14.2.3.Thermo Fisher Scientific Inc.,
14.2.4.Siemens AG
14.2.5.Bio Rad Laboratories Inc.
14.2.6.GE Healthcare,
14.2.7.Illumina, Inc.
14.2.8.Koninklijke Philips N.V.
14.2.9.Toshiba Medical Systems Corporation
15. Research Methodology 
16. Appendix and Abbreviations 
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.,
  • Siemens AG
  • Bio Rad Laboratories Inc.
  • GE Healthcare,
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Toshiba Medical Systems Corporation

Adjacent Markets